Home PageHome Page


Test Code
Supplies available from PAML Supply Department.
Supply Item Numberpicture9720
Specimen TypeFrozen urine
Preferred Volume5 mL
Patient PrepTesting with the Matritech NMP22® should not be performed on patients who have had a total cystectomy or an invasive procedure, such as cystoscopy or catheterization of the urethra, within five days.
Collection ProcedureCollect a single void of urine between midnight and noon. Immediately following collection, add urine to NMP22 urine stabilizer vial and freeze.
Specimen ProcessingStabilized urine should be blue-green.
Store and TransportFrozen
StabilityRoom Temp 2 days  Refrigerated 3 days  Frozen (-20 °C) 1 month  
Unacceptable ConditionNonstabilized urine
CPT Codes86316 x 1
Interface Order Code86316.Z3
Billing CodeNMP22
Test ScheduleMon, Thu
Turnaround Time2-8 days
Reference Ranges
The NMP22 assay is intended as an aid in the management of patients with transitional cell carcinoma of the urinary tract (TCC/UT). It is used after surgical treatment to identify patients with residual or rapidly recurring TCC/UT.
NotesValues obtained with different assay methods should not be used interchangeably. ARUP uses the Matritech NMP22 Test Kit, which is an EIA method.
Urine stabilization kit is available from the PAML Supply Department.

Interface Codes
typeorder codetest descriptionresult coderesult descriptionunitsdecimal placesloinc code
o86316.Z3NMP 22